Patent details
EP2225377 Title: LNA ANTAGONISTS TARGETING THE ANDROGEN RECEPTOR
Basic Information
- Publication number:
- EP2225377
- PCT Application Number:
- PCT/DK/2008/000417
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088556972
- PCT Publication Number:
- WO/2009/068033
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LNA ANTAGONISTS TARGETING THE ANDROGEN RECEPTOR
- French Title of Invention:
- ANTAGONISTES BASÉS SUR LES LNA CIBLANT LE RÉCEPTEUR DE L'ANDROGÈNE
- German Title of Invention:
- LNA-ANTAGONISTEN MIT ANDROGENREZEPTOR ALS ZIEL
- SPC Number:
Dates
- Filing date:
- 26/11/2008
- Grant date:
- 08/01/2014
- EP Publication Date:
- 08/01/2014
- PCT Publication Date:
- 04/06/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/09/2010
- EP B1 Publication Date:
- 08/01/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/11/2014
- Expiration date:
- 26/11/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/11/2008
- Name:
- Santaris Pharma A/S
- Address:
- Fremtidsvej 3, 2970 Hørsholm, Denmark (DK)
Inventor
- Name:
- WORM Jesper
- Address:
- Denmark (DK)
Priority
- Priority Number:
- 990125 P
- Priority Date:
- 26/11/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12N 15/113;
| Filing date | Document type | Number of pages |
|---|